Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Nurix (NRIX)

April 9, 2026 5:00 AM
BTIG analyst Jeet Mukherjee reiterated a Buy rating and $30.00 price target on Nurix (NASDAQ: NRIX)The analyst comments "NRIX reported ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments